First Time Loading...

Medadvisor Ltd
ASX:MDR

Watchlist Manager
Medadvisor Ltd Logo
Medadvisor Ltd
ASX:MDR
Watchlist
Price: 0.275 AUD Market Closed
Updated: Mar 28, 2024

Intrinsic Value

MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. [ Read More ]

The intrinsic value of one MDR stock under the Base Case scenario is 0.243 AUD. Compared to the current market price of 0.275 AUD, Medadvisor Ltd is Overvalued by 12%.

Key Points:
MDR Intrinsic Value
Base Case
0.243 AUD
Overvaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medadvisor Ltd

Backtest MDR Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MDR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Financials

Balance Sheet Decomposition
Medadvisor Ltd

Current Assets 28.1m
Cash & Short-Term Investments 14.3m
Receivables 11.7m
Other Current Assets 2.1m
Non-Current Assets 67.8m
PP&E 1.4m
Intangibles 66.4m
Other Non-Current Assets 17.1k
Current Liabilities 33.2m
Accounts Payable 4.2m
Accrued Liabilities 5.6m
Other Current Liabilities 23.4m
Non-Current Liabilities 14.3m
Long-Term Debt 12.3m
Other Non-Current Liabilities 2m
Efficiency

Earnings Waterfall
Medadvisor Ltd

Revenue
109.4m AUD
Cost of Revenue
-45m AUD
Gross Profit
64.4m AUD
Operating Expenses
-70.5m AUD
Operating Income
-6m AUD
Other Expenses
-3m AUD
Net Income
-9m AUD

Free Cash Flow Analysis
Medadvisor Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

MDR Profitability Score
Profitability Due Diligence

Medadvisor Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROIC is Increasing
ROE is Increasing
34/100
Profitability
Score

Medadvisor Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

MDR Solvency Score
Solvency Due Diligence

Medadvisor Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Negative Net Debt
Short-Term Solvency
41/100
Solvency
Score

Medadvisor Ltd's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MDR Price Targets Summary
Medadvisor Ltd

Wall Street analysts forecast MDR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDR is 0.411 AUD with a low forecast of 0.384 AUD and a high forecast of 0.462 AUD.

Lowest
Price Target
0.384 AUD
40% Upside
Average
Price Target
0.411 AUD
50% Upside
Highest
Price Target
0.462 AUD
68% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

MDR Price
Medadvisor Ltd

1M 1M
-17%
6M 6M
+20%
1Y 1Y
+10%
3Y 3Y
-21%
5Y 5Y
-88%
10Y 10Y
-78%
Annual Price Range
0.275
52w Low
0.17
52w High
0.33
Price Metrics
Average Annual Return -27.17%
Standard Deviation of Annual Returns 41.75%
Max Drawdown -100%
Shares Statistics
Market Capitalization 151.2m AUD
Shares Outstanding 549 866 000
Percentage of Shares Shorted
N/A

MDR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Medadvisor Ltd Logo
Medadvisor Ltd

Country

Australia

Industry

Health Care

Market Cap

151.2m AUD

Dividend Yield

0%

Description

MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm is engaged in the development and delivering software for personal medication management. The Company’s products include MedAdvisor App, PlusOne pharmacy platform. MedAdvisor App and its supporting software platform provides individuals and minders to manage all aspects of prescription medication use. Its cloud-based medication records and data connects pharmacies and other HCPs. The firm provides pharmaceutical health program..

Contact

VICTORIA
Melbourne
L 2 971 Burke Road, Camberwell
https://www.medadvisor.com.au

IPO

2011-05-26

Employees

-

Officers

CEO, MD & Director
Mr. Richard Ratliff
CFO & Joint Company Secretary
Ms. Ancila Desai B.Com., C.A., M.B.A.
Acting Chief Technology Officer
Mr. Craig Schnuriger
Executive VP of US & Client Relations
Mr. James M. Rotsart R.Ph.
President of ANZ
Mr. Wayne Marinoff
Joint Company Secretary
Ms. Anshu Raghuvanshi

See Also

Discover More
What is the Intrinsic Value of one MDR stock?

The intrinsic value of one MDR stock under the Base Case scenario is 0.243 AUD.

Is MDR stock undervalued or overvalued?

Compared to the current market price of 0.275 AUD, Medadvisor Ltd is Overvalued by 12%.